{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:58:13Z","timestamp":1791003493689,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.940507\/2024-00"],"award-info":[{"award-number":["88887.940507\/2024-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado do Amazonas","doi-asserted-by":"crossref","award":["010\/2023"],"award-info":[{"award-number":["010\/2023"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009648","name":"National Health Fund","doi-asserted-by":"crossref","award":["23070.047965\/2019-56"],"award-info":[{"award-number":["23070.047965\/2019-56"]}],"id":[{"id":"10.13039\/100009648","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10096-025-05071-2","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:46:56Z","timestamp":1739573216000},"page":"985-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Multicenter evaluation of leprosy rapid test Fast ML Flow Hansen\u00edase in Brazil"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2664-3800","authenticated-orcid":false,"given":"Djairo Pastor","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-3137","authenticated-orcid":false,"given":"Maur\u00edcio Lisboa","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-7958","authenticated-orcid":false,"given":"Rafael Alves","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8465-6124","authenticated-orcid":false,"given":"Matheus Bernardes Torres","family":"Foga\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-3223","authenticated-orcid":false,"given":"Isabela Maria Bernardes","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaison Ant\u00f4nio","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-769X","authenticated-orcid":false,"given":"V\u00e2nia Nieto Brito","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9904","authenticated-orcid":false,"given":"Selma Maria Bezerra","family":"Jeronimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9474-5764","authenticated-orcid":false,"given":"Francianne Medeiros","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-3002","authenticated-orcid":false,"given":"Tatiana Pereira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-4227","authenticated-orcid":false,"given":"Roberta Olmo","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-4315","authenticated-orcid":false,"given":"Mariane Martins de Ara\u00fajo","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-7770","authenticated-orcid":false,"given":"Samira","family":"B\u00fchrer-S\u00e9kula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"5071_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8652062","volume":"2022","author":"K-H Chen","year":"2022","unstructured":"Chen K-H, Lin C-Y, Su S-B, Chen K-T (2022) Leprosy: a review of epidemiology, clinical diagnosis, and management. J Trop Med 2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/8652062","journal-title":"J Trop Med"},{"key":"5071_CR2","doi-asserted-by":"publisher","unstructured":"Collin SM, Lima A, Heringer S, Sanders V, Pessotti HA, Deps P (2023) Systematic review of Hansen disease attributed to mycobacterium lepromatosis. Emerg. Infect Dis 29. https:\/\/doi.org\/10.3201\/eid2907.230024","DOI":"10.3201\/eid2907.230024"},{"key":"5071_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","volume":"130","author":"XY Han","year":"2008","unstructured":"Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS et al (2008) A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 130:856\u2013864. https:\/\/doi.org\/10.1309\/AJCPP72FJZZRRVMM","journal-title":"Am J Clin Pathol"},{"key":"5071_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","volume":"19","author":"DM Scollard","year":"2006","unstructured":"Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19:338\u2013381. https:\/\/doi.org\/10.1128\/CMR.19.2.338-381.2006","journal-title":"Clin Microbiol Rev"},{"key":"5071_CR5","unstructured":"WHO (1988) WHO Expert committee on leprosy:Sixth Report. 768. https:\/\/iris.who.int\/bitstream\/handle\/10665\/37409\/WHO_TRS_768.pdf?sequence=1. Accessed 13 Feb 2025"},{"key":"5071_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00567","volume":"11","author":"Z Mi","year":"2020","unstructured":"Mi Z, Liu H, Zhang F (2020) Advances in the immunology and genetics of leprosy. Front Immunol 11:1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2020.00567","journal-title":"Front Immunol"},{"key":"5071_CR7","unstructured":"WHO (2018) Guidelines for the diagnosis, treatment and prevention of leprosy. WHO: 1\u201387. https:\/\/iris.who.int\/bitstream\/handle\/10665\/274127\/9789290226383-eng.pdf?sequence=58. Accessed 13 Feb 2025"},{"key":"5071_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/brain\/awab396","volume":"145","author":"PJ Tomaselli","year":"2022","unstructured":"Tomaselli PJ, dos Santos DF, dos Santos ACJ, Antunes DE, Marques VD, Foss NT et al (2022) Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression. Brain 145:1499\u20131506. https:\/\/doi.org\/10.1093\/brain\/awab396","journal-title":"Brain"},{"key":"5071_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5935\/0305-7518.19620014","volume":"33","author":"DS Ridley","year":"1962","unstructured":"Ridley DS, Jopling WH (1962) A classification of leprosy for research purposes. Lepr Rev 33:119\u2013128. https:\/\/doi.org\/10.5935\/0305-7518.19620014","journal-title":"Lepr Rev"},{"key":"5071_CR10","first-page":"255","volume":"34","author":"DS Ridley","year":"1966","unstructured":"Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34:255\u2013273","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"5071_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00604","volume":"9","author":"S Sadhu","year":"2018","unstructured":"Sadhu S, Mitra DK (2018) Emerging concepts of adaptive immunity in leprosy. Front Immunol 9:1\u20137. https:\/\/doi.org\/10.3389\/fimmu.2018.00604","journal-title":"Front Immunol"},{"key":"5071_CR12","first-page":"614","volume":"54","author":"PEM Fine","year":"1986","unstructured":"Fine PEM, Job CK, McDougall AC, Meyers WM, Ponnighaus JM (1986) Comparability among histopathologists in the diagnosis and classification of lesions suspected of leprosy in Malawi. Int J Lepr 54:614\u2013625","journal-title":"Int J Lepr"},{"key":"5071_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5935\/0305-7518.19890031","volume":"60","author":"SB Lucas","year":"1989","unstructured":"Lucas SB, Ridley DS (1989) The use of histopathology in leprosy diagnosis and research. Lepr Rev 60:257\u2013262. https:\/\/doi.org\/10.5935\/0305-7518.19890031","journal-title":"Lepr Rev"},{"key":"5071_CR14","doi-asserted-by":"publisher","unstructured":"Alecrin ES de, Oliveira ALG de, Guimar\u00e3es NS, Lyon S, Martins MAP, Rocha MO da C (2022) Factors associated with the development of leprosy in Brazilian contacts: a systematic review. Rev Inst Med Trop Sao Paulo 64. https:\/\/doi.org\/10.1590\/s1678-9946202264055","DOI":"10.1590\/s1678-9946202264055"},{"key":"5071_CR15","doi-asserted-by":"publisher","unstructured":"Lopes-Luz L, Saavedra DP, Foga\u00e7a MBT, B\u00fchrer-S\u00e9kula S, Stefani MM de A (2023) Challenges and advances in serological and molecular tests to aid leprosy diagnosis. Exp Biol Med 2083\u201394. https:\/\/doi.org\/10.1177\/15353702231209422","DOI":"10.1177\/15353702231209422"},{"key":"5071_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0004703","volume":"10","author":"MLF Penna","year":"2016","unstructured":"Penna MLF, Penna GO, Iglesias PC, Natal S, Rodrigues LC (2016) Anti-PGL-1 positivity as a risk marker for the development of leprosy among contacts of leprosy cases: systematic review and meta-analysis. PLoS Negl Trop Dis 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pntd.0004703","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR17","first-page":"456","volume":"68","author":"S Buhrer-Sekula","year":"2000","unstructured":"Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JAC et al (2000) Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis 68:456\u2013463","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"5071_CR18","first-page":"192","volume":"61","author":"RV Cellona","year":"1993","unstructured":"Cellona RV, Walsh GP, Fajardo TT, Abalos RM, Dela Cruz EC, Guido- Villahermosa L et al (1993) Cross-sectional assessment of ELISA reactivity in leprosy patients, contacts, and normal population using the semisynthetic antigen natural disaccharide octyl bovine serum albumin (ND-O-BSA) in Cebu, The Philippines. Int J Lepr 61:192\u2013198","journal-title":"Int J Lepr"},{"key":"5071_CR19","first-page":"480","volume":"58","author":"PW Roche","year":"1990","unstructured":"Roche PW, Britton WJ, Failbus SS, Williams D, Pradhan HM, Theuvenet WJ (1990) Operational value of serological measurements in multibacillary leprosy patients: Clinical and bacteriological correlates of antibody responses. Int J Lepr 58:480\u2013490","journal-title":"Int J Lepr"},{"key":"5071_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/CDLI.8.1.138-142.2001","volume":"8","author":"SN Cho","year":"2001","unstructured":"Cho SN, Cellona RV, Villahermosa LG, Fajardo J, Balagon MVF, Abalos RM et al (2001) Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin Diagn Lab Immunol 8:138\u2013142. https:\/\/doi.org\/10.1128\/CDLI.8.1.138-142.2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"5071_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.47276\/lr.77.4.343","volume":"77","author":"RP Schuring","year":"2006","unstructured":"Schuring RP, Moet FJ, Pahan D, Richardus JH, Oskam L (2006) Association between anti-PGL-I IgM and clinical and demographic parameters in leprosy. Lepr Rev 77:343\u2013355","journal-title":"Lepr Rev"},{"key":"5071_CR22","doi-asserted-by":"publisher","first-page":"e0006083","DOI":"10.1371\/journal.pntd.0006083","volume":"11","author":"RA Richardus","year":"2017","unstructured":"Richardus RA, van der Zwet K, van Hooij A, Wilson L, Oskam L, Faber R et al (2017) Longitudinal assessment of anti-PGL-I serology in contacts of leprosy patients in Bangladesh. PLoS Negl Trop Dis 11:e0006083. https:\/\/doi.org\/10.1371\/journal.pntd.0006083","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR23","unstructured":"Brasil (2021) Teste r\u00e1pido imunocromatogr\u00e1fico para determina\u00e7\u00e3o qualitativa de anticorpos IgM anti-Mycobacterium leprae para diagn\u00f3stico complementar de Hansen\u00edase [Internet]. http:\/\/antigo-conitec.saude.gov.br\/images\/Relatorios\/2021\/20220103_Relatorio_teste-rapido_hanseniase_689.pdf. Accessed 13 Feb 2025"},{"key":"5071_CR24","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1128\/JCM.41.5.1991-1995.2003","volume":"41","author":"S B\u00fchrer-S\u00e9kula","year":"2003","unstructured":"B\u00fchrer-S\u00e9kula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T et al (2003) Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 41:1991\u20131995. https:\/\/doi.org\/10.1128\/JCM.41.5.1991-1995.2003","journal-title":"J Clin Microbiol"},{"key":"5071_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00415-003-1081-5","volume":"250","author":"MR Jardim","year":"2003","unstructured":"Jardim MR, Antunes SLG, Santos AR, Nascimento OJM, Nery JAC, Sales AM et al (2003) Criteria for diagnosis of pure neural leprosy. J Neurol 250:806\u2013809. https:\/\/doi.org\/10.1007\/s00415-003-1081-5","journal-title":"J Neurol"},{"key":"5071_CR26","doi-asserted-by":"publisher","first-page":"e0006494","DOI":"10.1371\/journal.pntd.0006494","volume":"12","author":"DF dos Santos","year":"2018","unstructured":"dos Santos DF, Mendon\u00e7a MR, Antunes DE, Sabino EFP, Pereira RC, Goulart LR et al (2018) Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts. PLoS Negl Trop Dis 12:e0006494. https:\/\/doi.org\/10.1371\/journal.pntd.0006494","journal-title":"PLoS Negl Trop Dis"},{"key":"5071_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5025\/hansen1977.50.22","volume":"50","author":"G Ramu","year":"1981","unstructured":"Ramu G (1981) The Indian Classification of Leprosy. Japanese J Lepr 50:226\u201332. https:\/\/doi.org\/10.5025\/hansen1977.50.22","journal-title":"Japanese J Lepr"},{"key":"5071_CR28","unstructured":"World Health Organization (1998) WHO Expert Committee on Leprosy: Seventh Report. https:\/\/iris.who.int\/handle\/10665\/42060. Accessed 13 Feb 2025"},{"key":"5071_CR29","doi-asserted-by":"publisher","unstructured":"Foga\u00e7a MBT, Saavedra DP, Sousa MB de J, de Oliveira NKAB, Stefani MM de A, Buhrer-S\u00e9kula S (2024) Long-term storage stability of PGL-I coated ELISA plates for anti-Mycobacterium leprae IgM detection. J Microbiol Methods 224. https:\/\/doi.org\/10.1016\/j.mimet.2024.106985","DOI":"10.1016\/j.mimet.2024.106985"},{"key":"5071_CR30","doi-asserted-by":"publisher","unstructured":"do Carmo Gon\u00e7alves A, Hungria EM, Freitas AA, S\u00e9kula-B\u00fchrer S, Gomes CM, Coelho AC, et al (2020) Leprosy surveillance study in a highly endemic Brazilian area using leprosy specific serologic tests and IFN\u03b3 whole blood assay. Eur J Clin Microbiol Infect Dis 39:2345\u201360. https:\/\/doi.org\/10.1007\/s10096-020-03979-5","DOI":"10.1007\/s10096-020-03979-5"},{"key":"5071_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1590\/S0037-86822008000700017","volume":"41","author":"S B\u00fchrer-S\u00e9kula","year":"2008","unstructured":"B\u00fchrer-S\u00e9kula S, van Beers S, Oskam L, Lecco R, Madeira ES, Dutra MAL et al (2008) The relation between seroprevalence of antibodies against phenolic glycolipid-I among school children and leprosy endemicity in Brazil. Rev Soc Bras Med Trop 41:81\u201388. https:\/\/doi.org\/10.1590\/S0037-86822008000700017","journal-title":"Rev Soc Bras Med Trop"},{"key":"5071_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1037\/h0031619","volume":"76","author":"JL Fleiss","year":"1971","unstructured":"Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76:378\u2013382. https:\/\/doi.org\/10.1037\/h0031619","journal-title":"Psychol Bull"},{"key":"5071_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2528928","volume":"27","author":"SR Searle","year":"1971","unstructured":"Searle SR (1971) A Biometrics Invited Paper. Topics Variance Component Estimation Biom 27:1. https:\/\/doi.org\/10.2307\/2528928","journal-title":"Topics Variance Component Estimation Biom"},{"key":"5071_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fitd.2022.893653","volume":"3","author":"M Sharma","year":"2022","unstructured":"Sharma M, Singh P (2022) Advances in the diagnosis of leprosy. Front Trop Dis 3:1\u201310. https:\/\/doi.org\/10.3389\/fitd.2022.893653","journal-title":"Front Trop Dis"},{"key":"5071_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.47276\/lr.79.2.162","volume":"79","author":"S Lyon","year":"2008","unstructured":"Lyon S, Lyon AC, da Silva RC, de FariaGrossi MA, Lyon SH, B\u00fchrer-S\u00e9kula S et al (2008) A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil. Lepr Rev 79:162\u201370. https:\/\/doi.org\/10.47276\/lr.79.2.162","journal-title":"Lepr Rev"},{"key":"5071_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.47276\/lr.78.1.70","volume":"78","author":"S B\u00fchrer-S\u00e9kula","year":"2007","unstructured":"B\u00fchrer-S\u00e9kula S, Visschedijk J, Grossi MAF, Dhakal KP, Namadi AU, Klatser PR et al (2007) The ML Flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients. Lepr Rev 78:70\u20139. https:\/\/doi.org\/10.47276\/lr.78.1.70","journal-title":"Lepr Rev"},{"key":"5071_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1590\/S0037-86822008000700004","volume":"41","author":"RS De Moura","year":"2008","unstructured":"De Moura RS, Calado KL, Oliveira MLW, B\u00fchrer-S\u00e9kula S (2008) Sorologia da hansen\u00edase utilizando PGL-I: Revis\u00e3o sistem\u00e1tica. Rev Soc Bras Med Trop 41:11\u201318. https:\/\/doi.org\/10.1590\/S0037-86822008000700004","journal-title":"Rev Soc Bras Med Trop"},{"key":"5071_CR38","doi-asserted-by":"publisher","unstructured":"Hungria EM, Oliveira RM, Penna GO, Aderaldo LC, Pontes MA de A, Cruz R, et al (2016) Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil. Infect Dis Poverty 5:1\u201310. https:\/\/doi.org\/10.1186\/s40249-016-0203-0","DOI":"10.1186\/s40249-016-0203-0"},{"key":"5071_CR39","doi-asserted-by":"publisher","unstructured":"Hungria EM, B\u00fchrer-S\u00e9kula S, de Oliveira RM, Aderaldo LC, Pontes A de A, Cruz R, et al (2017) Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT\/CT-BR). PLoS Negl Trop Dis 11:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0005396","DOI":"10.1371\/journal.pntd.0005396"},{"key":"5071_CR40","unstructured":"Brasil (2023) NOTA T\u00c9CNICA No 3\/2023-CGDE\/DEDT\/SVSA\/MS [Internet]. https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/saude-de-a-a-z\/h\/hanseniase\/publicacoes\/nota-tecnica-no-3-2023-cgde-dedt-svsa-ms\/view. Accessed 13 Feb 2025"},{"key":"5071_CR41","doi-asserted-by":"publisher","unstructured":"Cruz RC da S, B\u00fchrer-S\u00e9kula S, Penna MLF, Penna GO, Talhari S (2017) Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. An Bras Dermatol 92:761\u201373. https:\/\/doi.org\/10.1590\/abd1806-4841.20176724","DOI":"10.1590\/abd1806-4841.20176724"},{"key":"5071_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clindermatol.2014.07.002","volume":"33","author":"C Talhari","year":"2015","unstructured":"Talhari C, Talhari S, Penna GO (2015) Clinical aspects of leprosy. Clin Dermatol 33:26\u201337. https:\/\/doi.org\/10.1016\/j.clindermatol.2014.07.002","journal-title":"Clin Dermatol"},{"key":"5071_CR43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","volume":"102","author":"RL Modlin","year":"1994","unstructured":"Modlin RL (1994) Th1-Th2 Paradigm: Insights from Leprosy. J Invest Dermatol 102:828\u2013832. https:\/\/doi.org\/10.1111\/1523-1747.ep12381958","journal-title":"J Invest Dermatol"},{"key":"5071_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clindermatol.2014.07.005","volume":"33","author":"I Nath","year":"2015","unstructured":"Nath I, Saini C, Valluri VL (2015) Immunology of leprosy and diagnostic challenges. Clin Dermatol 33:90\u201398. https:\/\/doi.org\/10.1016\/j.clindermatol.2014.07.005","journal-title":"Clin Dermatol"},{"key":"5071_CR45","doi-asserted-by":"publisher","unstructured":"Dornelas BDC, Vargas W, Pablo J, Abreu F De, Daud S, Rodrigues A, et al (2024) Role of histopathological , serological and molecular findings for the early diagnosis of treatment failure in leprosy. 2.\u00a0https:\/\/doi.org\/10.1186\/s12879-024-09937-2","DOI":"10.1186\/s12879-024-09937-2"},{"key":"5071_CR46","doi-asserted-by":"publisher","unstructured":"Saini C, Ramesh V, Nath I (2013) CD4+ Th17 Cells Discriminate Clinical Types and Constitute a Third Subset of Non Th1, Non Th2 T Cells in Human Leprosy. PLoS Negl Trop Dis 7. https:\/\/doi.org\/10.1371\/journal.pntd.0002338","DOI":"10.1371\/journal.pntd.0002338"},{"key":"5071_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ddr.20457","volume":"72","author":"M Simon","year":"2011","unstructured":"Simon M, Scherlock J, Duthie MS, Ribeiro de Jesus A (2011) Clinical, immunological, and genetic aspects in leprosy. Drug Dev Res 72:509\u2013527. https:\/\/doi.org\/10.1002\/ddr.20457","journal-title":"Drug Dev Res"},{"key":"5071_CR48","doi-asserted-by":"publisher","unstructured":"Antunes SLG, Chimelli L, Jardim MR, Vital RT, Nery JA da C, Corte-Real S, et al (2012) Histopathological examination of nerve samples from pure neural leprosy patients: obtaining maximum information to improve diagnostic efficiency. Mem Inst Oswaldo Cruz 107:246\u201353. https:\/\/doi.org\/10.1590\/S0074-02762012000200015","DOI":"10.1590\/S0074-02762012000200015"},{"key":"5071_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2023.1143402","volume":"10","author":"DF dos Santos","year":"2023","unstructured":"dos Santos DF, Garcia LP, Borges IS, Oliveira TJ, Antunes DE, Luppi ADM et al (2023) Early diagnosis of neural impairment in seropositive leprosy household contacts: The experience of a reference center in Brazil. Front Med 10:1\u20136. https:\/\/doi.org\/10.3389\/fmed.2023.1143402","journal-title":"Front Med"},{"key":"5071_CR50","doi-asserted-by":"publisher","first-page":"e0285450","DOI":"10.1371\/journal.pone.0285450","volume":"18","author":"ADM Luppi","year":"2023","unstructured":"Luppi ADM, Ferreira GE, Prud\u00eancio DL, Antunes DE, Ara\u00fajo L, dos Santos DF et al (2023) High-resolution ultrasonography for early diagnosis of neural impairment in seropositive leprosy household contacts. PLoS ONE 18:e0285450. https:\/\/doi.org\/10.1371\/journal.pone.0285450","journal-title":"PLoS ONE"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05071-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:11:23Z","timestamp":1743253883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05071-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Research Ethics Committee of Brazil (CAAE:38949520.0.0000.5078).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors disclose that this multicenter study compares the Bioclin Fast ML Flow Hansen\u00edase commercial test with other diagnostic methods. It is important to mention that the lead researcher of the coordinating center, S.B.S., has previously been involved in the technology transfer to Quibasa\u2014Qu\u00edmica B\u00e1sica LTDA, the company that owns this product. This relationship has been acknowledged to maintain transparency and uphold the integrity of the study\u2019s results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}